Bayesian Capital Management, LP Aurinia Pharmaceuticals Inc. Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$7.77 - $12.27 $150,738 - $238,038
19,400 New
19,400 $150,000
Q1 2023

May 15, 2023
BUY
$5.94 - $11.27 $130,680 - $247,940
22,000 New
22,000 $241,000
Q2 2022

Aug 15, 2022
BUY
$8.95 - $12.8 $288,037 - $411,942
32,183 New
32,183 $323,000
Q2 2018

Aug 14, 2018
SELL
$5.06 - $6.36 $82,478 - $103,668
-16,300 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$4.85 - $5.99 $79,055 - $97,637
16,300 New
16,300 $85,000

Others Institutions Holding AUPH

# of Institutions
208
Shares Held
58.1M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email